天津海关“胰岛素通关快线”服务生物医药产业高质量发展

Core Points - The Tianjin Binhai Airport Customs has launched an "Insulin Fast Track" to support the high-quality development of the biopharmaceutical industry in Tianjin [1][2] - From January to October this year, the value of imported insulin products through Tianjin's air port reached 8.943 billion RMB, representing a year-on-year increase of 1454.5% [1] - Novo Nordisk (China) Pharmaceutical Co., Ltd. successfully imported its 15th batch of insulin raw materials at Tianjin Binhai Airport Customs this year [1] Customs Initiatives - The customs has established a "dedicated window" and a "customs-enterprise liaison officer" mechanism to provide one-on-one policy guidance and problem-solving for enterprises [1] - A special customs guarantee plan has been developed for insulin products, with a "report and review on demand" process for goods that do not require inspection, ensuring zero delay in the customs process [1] - The customs encourages enterprises to utilize the "advance declaration" model to streamline document review, allowing for immediate release of goods upon arrival [1] Future Plans - The Tianjin Binhai Airport Customs aims to continue deepening reform and innovation, optimizing the port business environment, and supporting the high-quality development of the biopharmaceutical industry [2]